Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest proteomics Stories

2013-10-17 08:29:09

Series A investors include 5AM Ventures, Pfizer Venture Investments and Roche Venture Fund BURLINGAME, Calif., Oct. 17, 2013 /PRNewswire/ -- Biodesy, Inc., a privately held developer of novel systems to analyze real-time protein function for research and clinical applications, announced today that it has closed a $15.0 million Series A venture financing round from 5AM Ventures, Pfizer Venture Investments and Roche Venture Fund. In addition, Greg Yap has been named Chief Executive...

2013-10-16 16:25:45

Breakthrough Technology Powered by Advanced MRM-Mass Spec Protein Detection Provides Scientific Validation of Caprion's Proteomics Biomarker Discovery Technologies and Partnership-Driven Business Model MONTREAL, Oct. 16, 2013 /PRNewswire/ - Caprion Proteomics announced today the results of a major study conducted by Indi (Integrated Diagnostics), an emerging leader in molecular diagnostics that has been actively collaborating with Caprion since 2008, which suggests that...

2013-10-09 16:22:35

ReportsnReports.com offers Analysis of Global Biochips Industry, 2012-2018 market research report that reviews the latest biochips market trends with a perceptive attempt to disclose the near-future growth prospects. DALLAS, Oct. 9, 2013 /PRNewswire-iReach/ -- Analysis of Global Biochips Industry, 2012-2018 market research report forecasts the global biochips market to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific...

2013-10-09 08:27:02

SAN DIEGO and HEIDELBERG, Germany, Oct. 9, 2013 /PRNewswire/ -- Applied Proteomics Inc. (API), the leading developer of protein-based molecular diagnostics, announces a collaboration with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), the largest biomedical research institute in Germany. Under the collaboration, API and DKFZ will advance the discovery and development of new blood tests for colon and pancreatic cancer. "Both API and the German Cancer...

2013-10-08 23:03:42

In-demand research report “Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 – 2018” prepared by MarketsandMarkets has been recently published by Market Publishers Ltd. London, UK (PRWEB) October 08, 2013 In 2012, the world cancer/tumor profiling market surpassed a USD 13.25 billion mark. At...

2013-10-07 23:24:06

The global market for sample preparation reagents and products used in life science research was valued at $4.6 billion in 2012 and is expected to reach $5.4 billion by 2013. BCC Research projects the market to grow to $11.5 billion in 2018, and register a five-year compound annual growth rate (CAGR) of 16.3% from 2013 to 2018. Wellesley, MA (PRWEB) October 07, 2013 According to a new technical market research report, Sample Preparation in Genomics, Proteomics and Epigenomics: Global...

2013-09-29 23:01:19

The report “Biomarkers Market – ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) – Global Trends & Forecasts (2013 – 2018)” says global biomarkers market shows a high growth potential and accounts for $17.5 billion in 2013. Dallas, Texas (PRWEB) September 29, 2013 A biomarker is an identifiable and measurable characteristic, which...

2013-09-27 23:20:55

The report “Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 – 2018” says cancer/tumor profiling market is valued at $14.99 billion in 2013 and is expected to reach $35.03 billion by 2018. Dallas, Texas (PRWEB) September 27, 2013 Cancer/Tumor profiling is a promising market and is witnessing...

2013-09-27 12:25:55

DUBLIN, September 27, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/hg72tl/metabolomics) have announced the addition of the "The Global Metabolomics Market 2013 Report" [http://www.researchandmarkets.com/research/hg72tl/metabolomics ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Over the last decade, genomics and proteomics have been used as key tools to discover potential drug...

2013-09-25 08:29:33

G3's Cardiovascular Disease Biomarker and Drug Target Discovery Study (the "GLOBAL" Study) is the Single Largest Prospective Pan-Omic Study to Employ Whole Genome Sequencing RICHMOND, Va., and SAN DIEGO, Sept. 25, 2013 /PRNewswire/ -- Global Genomics Group (G3) and Illumina, Inc. (NASDAQ: ILMN) today announced that they have entered into a partnership to investigate novel biomarkers and biological pathways involved in the development and diagnosis of cardiovascular diseases. Under...